Newave Pharmaceutical Inc
Clinical trials sponsored by Newave Pharmaceutical Inc, explained in plain language.
-
New hope for tough blood cancers: LP-118 trial launches
Disease control Recruiting nowThis early-stage study tests a new oral drug, LP-118, in up to 100 adults with blood cancers like lymphoma, leukemia, or myeloma that returned or didn't respond to prior therapy. The main goals are to find the safest dose and see if the drug can shrink tumors or slow the disease.…
Phase: PHASE1 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
New pill takes on tough blood cancers in early human trial
Disease control Recruiting nowThis early-stage study tests an experimental oral drug, LP-168, in about 60 people with certain blood cancers (like CLL, lymphoma) that have returned or not responded to prior treatments. The main goals are to find the safest dose and understand how the drug works in the body. Re…
Phase: PHASE1 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
New drug rocbrutinib takes on pirtobrutinib in blood cancer showdown
Disease control Recruiting nowThis study tests a new drug, rocbrutinib, against another drug, pirtobrutinib, in people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) whose cancer has returned or stopped responding to treatment. All participants have already tried a type of BTK inh…
Phase: PHASE3 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC